Decision Making and Patient Preferences Prior to Surgery
Katharine Yao, MD, gives an overview of an analysis that looked at patient preferences prior to surgery.
Clinical Pearls
Katharine Yao, MD, director, breast surgical program, NorthShore University HealthSystem, Evanston, Illinois, clinical associate professor, surgery, Pritzker School of Medicine, University of Chicago, gives an overview of an analysis that looked at patient preferences prior to surgery.
- This survey focused on surgery choices and treatment preferences before surgery.
- 57.8% of patients considered a contralateral prophylactic mastectomy during the decision making process.
- 39.8% of patients thought about their surgery choice prior to getting breast cancer.
<<<
Therapy Type and Site of Metastases Factor into HR+, HER2+ mBC Treatment
December 20th 2024During a Case-Based Roundtable® event, Ian Krop, MD, and participants discussed considerations affecting first- and second-line treatment of metastatic HER2-positive breast cancer in the first article of a 2-part series.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
ctDNA Detection Tied to Tumor Burden, Recurrence in HR+ Early Breast Cancer
December 13th 2024A phase 2 trial showed ctDNA detection in HR-positive early breast cancer was linked to larger tumors, higher residual cancer burden, and increased recurrence after neoadjuvant endocrine therapy.
Read More
